YS-HBV-002
N/A
Report date: 2025/03/19 16:06:36
Base Information
Drug NameYS-HBV-002
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLakeShore Biopharma Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesLakeShore Biopharma Co Ltd
Inactive CompaniesYisheng Biopharma (Singapore) Pte Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A